Showing results (2181-2190 of 2,334) with videos related to
Sort By:
Pageof 234
Journal of Clinical Microbiology|October 30, 2001
Development and evaluation of serotype- and group-specific fluorogenic reverse transcriptase PCR (TaqMan) assays for dengue virusJ D Callahan, S J Wu, A Dion-Schultz, et al.BMJ (Clinical Research Ed.)|April 16, 2011
Overnight closed loop insulin delivery (artificial pancreas) in adults with type 1 diabetes: crossover randomised controlled studiesRoman Hovorka, Kavita Kumareswaran, Julie Harris, et al.Cardiovascular Research|January 19, 2017
SK channel enhancers attenuate Ca2+-dependent arrhythmia in hypertrophic hearts by regulating mito-ROS-dependent oxidation and activity of RyRTae Yun Kim, Radmila Terentyeva, Karim H F Roder, et al.Diabetic Medicine : a Journal of the British Diabetic Association|April 3, 2023
Interventions to enhance pre-pregnancy care for women with type 2 diabetes: A systematic review of the literatureLily Hopkins, Angus Forbes, Janet E Anderson, et al.Journal of Comparative Psychology (Washington, D.C. : 1983)|February 10, 2017
Characterization of vocalizations emitted in isolation by California mouse (Peromyscus californicus) pups throughout the postnatal periodSarah A Johnson, Michele S Painter, Angela B Javurek, et al.Biochemical Pharmacology|March 9, 2006
Preclinical analysis of the analinoquinazoline AG1478, a specific small molecule inhibitor of EGF receptor tyrosine kinaseA G Ellis, M M Doherty, F Walker, et al.Vaccine|July 31, 2007
Recombinant human parainfluenza virus type 2 vaccine candidates containing a 3' genomic promoter mutation and L polymerase mutations are attenuated and protective in non-human primatesSheila M Nolan, Mario H Skiadopoulos, Konrad Bradley, et al.Vaccine|January 13, 2006
Transmissibility, infectivity and immunogenicity of a live human parainfluenza type 3 virus vaccine (HPIV3cp45) among susceptible infants and toddlersShabir A Madhi, Clare Cutland, Yuwei Zhu, et al.American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|September 12, 2015
One-year post-discharge resource utilization and treatment patterns of patients with acute coronary syndrome managed with percutaneous coronary intervention and treated with ticagrelor or prasugrelJason C Simeone, Cliff Molife, Elizabeth Marrett, et al.Journal of Clinical Pharmacology|September 16, 2003
A review and assessment of potential sources of ethnic differences in drug responsivenessThorir D Bjornsson, John A Wagner, Stephen R Donahue, et al.Pageof 234